switching from compounded tirzepatide to zepbound FDA Says Must Exit the Market Switch from Zepbound to compounded,

However, the risk is often associated with the dose

I have been using this for a month now and very happy with the results

The injection is administered using a small insulin needle, and most patients report feeling only a slight pinch with no lingering discomfort

Clinical studies showed that patients on Tirzepatide lose more weight than those on Ozempic, some trials reported up to 15% body weight loss on Tirzepatide vs 10% on Ozempic

If you know or suspect your tirzepatide has been exposed to temperatures outside the 36-86F range, or if an unopened pen/syringe has been at room temperature for more than 21 days, the medication should be discarded regardless of appearance